Mary S. Anthony, PhD

Senior Director, Epidemiology
RTI International Health Solutions
Thousand Oaks, United States

Disclosure information not submitted.

Presentation(s):

• Considerations for Negative Control Outcome Analyses in Vaccine Effectiveness Studies: Post-Hoc Analyses from an Adult Vaccine Effectiveness Study conducted within the FDA BEST Initiative

  Tuesday, August 27, 2024
  8:30 AM - 8:45 AM CEST

• Effectiveness Over Time of a Complete Primary Series of the Original, Monovalent COVID-19 Vaccines Among Adults Aged 18-64 Years in the United States

  Tuesday, August 27, 2024
  9:15 AM - 9:30 AM CEST

• Events on Day Zero of Follow-Up: Considerations for Cohort Studies of Adverse Events After COVID-19 Diagnosis

  Tuesday, August 27, 2024
  1:00 PM - 1:15 PM CEST

• Risk of Neurologic or Immune-Mediated Adverse Events After COVID-19 Diagnosis in the United States

  Wednesday, August 28, 2024
  1:30 PM - 1:45 PM CEST

• Risk of Cardiovascular Adverse Events After COVID-19 Diagnosis in the United States

  Wednesday, August 28, 2024
  2:45 PM - 3:00 PM CEST